Treatment of ESCC cells with the NF-κB inhibitor PDTC blocked the ability of RELT to protect ESCC cells from death, implying that RELT serves as an oncogene in ESCC cells by upregulating NF-κB. Here, NFKB1 is linked to esophageal squamous cell carcinoma.